David Dodd, a former CEO of Serologicals, is the new chairman and chief executive officer of BioReliance Corporation.

Dodd led Serologicals from 2000 to 2006.

BioReliance provides contract services for biologics safety testing, toxicology, viral manufacturing and animal diagnostics services to life science companies.